Showing results (311-320 of 389) with videos related to
Sort By:
Pageof 39
BMJ Open|January 5, 2020
Levofloxacin versus placebo for the treatment of latent tuberculosis among contacts of patients with multidrug-resistant tuberculosis (the VQUIN MDR trial): a protocol for a randomised controlled trialGreg J Fox, Cam Binh Nguyen, Thu Anh Nguyen, et al.Plos One|June 23, 2011
PCR improves diagnostic yield from lung aspiration in Malawian children with radiologically confirmed pneumoniaEnitan D Carrol, Limangeni A Mankhambo, Malcolm Guiver, et al.American Journal of Respiratory and Critical Care Medicine|June 2, 2015
Mycobacteria-Specific Cytokine Responses Detect Tuberculosis Infection and Distinguish Latent from Active TuberculosisMarc Tebruegge, Binita Dutta, Susan Donath, et al.ERJ Open Research|October 27, 2022
Prevalence and genetic basis of first-line drug resistance of Mycobacterium tuberculosis in Ca Mau, VietnamJack Callum, Phuong T B Nguyen, Elena Martinez, et al.The European Respiratory Journal|February 11, 2022
The burden of asthma, hay fever and eczema in children in 25 countries: GAN Phase I studyLuis García-Marcos, M Innes Asher, Neil Pearce, et al.The Journal of Allergy and Clinical Immunology|May 9, 2017
Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiologySteven L Taylor, Lex E X Leong, Jocelyn M Choo, et al.The European Respiratory Journal|October 28, 2017
Traffic-related air pollution exposure over a 5-year period is associated with increased risk of asthma and poor lung function in middle ageGayan Bowatte, Bircan Erbas, Caroline J Lodge, et al.Frontiers in Immunology|April 27, 2019
Mycobacteria-Specific Mono- and Polyfunctional CD4+ T Cell Profiles in Children With Latent and Active Tuberculosis: A Prospective Proof-of-Concept StudyMarc Tebruegge, Nicole Ritz, Susan Donath, et al.CNS Drugs|June 5, 2013
The safety, tolerability, and efficacy of once-daily memantine (28 mg): a multinational, randomized, double-blind, placebo-controlled trial in patients with moderate-to-severe Alzheimer's disease taking cholinesterase inhibitorsGeorge T Grossberg, Facundo Manes, Ricardo F Allegri, et al.Environmental Health Perspectives|March 22, 2023
The Health Effects of 72 Hours of Simulated Wind Turbine Infrasound: A Double-Blind Randomized Crossover Study in Noise-Sensitive, Healthy AdultsNathaniel S Marshall, Garry Cho, Brett G Toelle, et al.Pageof 39